powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1972930352
Narmada Movva
M.D.
Endocrinology
Attleboro,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
83.7
Quality
65.3
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.37%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
72
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K
PRESCRIBING · PART D · 2024
Total Rx claims
5,315
Beneficiaries
—
Total drug cost
$2.9M
Distinct drugs
43
Brand share
73.7%
Top prescribed drugs
Empagliflozin
571 claims
Semaglutide
517 claims
Levothyroxine Sodium
421 claims
Tirzepatide
232 claims
Insulin Glargine,hum.Rec.Anlog
225 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,381
Unique beneficiaries
—
Total services
13,009
Distinct HCPCS
16
Medicare payment
$224K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 341 Endocrinology providers in MA — top quintile (cohort median 496).
